两种分类标准的比较研究在Behçet病的实际临床实践中设置了两个分类标准
Rafael Gálvez-Sánchez1,2, José Luis Martín-Varillas2,3, Lara Sánchez-Bilbao1,2
1Rheumatology, Hospital Marqués de Valdecilla, 39008 Santander, Spain.
Journal of clinical medicine
|August 14, 2025
概括
贝赫塞特的国际标准
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 贝切特病 (BD) 的分类历史上依赖国际研究小组 (ISG) 的标准,需要口腔.
- 国际BD标准修订国际小组 (ICBD) 开发了一种评分系统,以改善分类.
- 需要在BD诊断中比较ISG与ICBD标准的敏感性和临床实用性.
研究的目的:
- 评估ISG和ICBD标准在贝塞特病中的敏感性和一致性.
- 评估这些标准的临床影响,特别是在严重的BD病例 (眼睛,血管,神经).
- 在一个明确定义的群体中比较诊断性能.
主要方法:
- 对142名在1980年至2023年期间被诊断为贝希特病患者的回顾性队列研究.
- 国际研究小组 (ISG) 和贝塞特病国际标准 (ICBD) 诊断标准的比较.
- 使用卡帕统计和流行调整和偏差调整的卡帕 (PABAK) 评估了敏感性和一致性.
主要成果:
- 在整个队列中,贝塞特病国际标准 (ICBD) 标准的敏感性 (81.6%) 比国际研究小组 (ISG) 标准 (59.1%) 高.
- 对于ICBD标准的敏感性在严重的贝塞特病病例中 (92.5%) 与ISG标准 (71.2%) 相比特别优越.
- 观察到适度的整体一致性 (Kappa = 0.490),与PABAK (0.549) 略有改善.
结论:
- 国际贝塞特病标准 (ICBD) 标准为诊断贝塞特病提供了更好的灵敏度,特别是在严重的表现.
- 使用ICBD标准确定了更多的患者,促进了及时启动生物疗法,包括抗TNF药物和apremilast.
- 这些发现表明,ICBD标准有助于改善贝塞特病的管理,特别是在严重表现的患者中.
相关概念视频
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
245
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
245
Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
Inflammatory Bowel Disease II: Crohn's Disease
383
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
383
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203


